Skip to content

Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors

Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors: A Prospective, Multicenter, Non-inferiority Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07759960
Enrollment
174
Registered
2026-08-12
Start date
2026-04-14
Completion date
2029-12-01
Last updated
2026-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Neuroendocrine Tumor

Brief summary

Underwater endoscopic mucosal resection (UEMR) and endoscopic submucosal dissection (ESD) have both been reported to be two effective treatment methods for small rectal neuroendocrine tumor (NET). However, there is no consensus on the best method for the endoscopic resection of rectal NET. Therefore, we aimed to compare the efficacy and safety of UEMR and ESD for the treatment of small rectal NET.

Detailed description

Researchers plan to conduct a prospective, multicenter, non-inferiority, randomized controlled trial to compare the efficacy and safety of UEMR and ESD for the treatment of small rectal NET in ten endoscopic centers in China.

Interventions

PROCEDUREUEMR procedure

Small rectal NET will be removed by underwater endoscopic mucosal resection. The UEMR procedure included the following: (1) complete deflation of the colorectal lumen; (2) total immersion of the lesion in normal saline using a mechanical water pump; (3)needle injection of normal saline into the submucosa; (4) snaring the lesion and the surrounding mucosa; and (5) resection using electrocautery.

PROCEDUREESD procedure

Small rectal NET will be removed by endoscopic submucosal dissection. The ESD procedure included the following: (1) dots were marked approximately 5 mm from the periphery of the lesion using coagulation; (2) a diluted sodium hyaluronate solution with indigo carmine dye was injected submucosally. (3) mucosal incision and submucosal dissection were performed using a T-Type ESD Knife (Micro-Tech, Nanjing, China) or Dual-knife (Olympus Medical, Tokyo, Japan); (4)after resection was completed, all visible vessels on the artificial wound were thoroughly coagulated to prevent postoperative bleeding.

Sponsors

Nanfang Hospital, Southern Medical University
Lead SponsorOTHER
Guangdong Provincial Hospital of Traditional Chinese Medicine
CollaboratorOTHER
The Eighth Affiliated Hospital of Southern Medical University
CollaboratorUNKNOWN
ZhuHai Hospital
CollaboratorOTHER
Shenzhen Longgang District People's Hospital
CollaboratorUNKNOWN
Jiangmen Central Hospital
CollaboratorOTHER
Yangjiang People's Hospital
CollaboratorOTHER
The Third People's Hospital of Huizhou
CollaboratorOTHER
the Fifth Affiliated Hospital of Zunyi Medical University (Zhuhai)
CollaboratorUNKNOWN
Ganzhou City People's Hospital
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Age from 18 to 75 years; 2. With a high suspicion or evidence of rectal NET assessed using EUS, CT scan or colonoscopy; 3. With tumor size ≤10 mm assessed by colonoscopy or EUS; 4. Plan to receive UEMR or ESD treatment and provide written informed consent.

Exclusion criteria

1. Unable to tolerate ESD or UEMR as assessed by the research team; 2. Complicated with serious diseases such as malignant tumor, which may lead to shorter life expectancy, the research team considers that it is not suitable for inclusion in the study after comprehensive evaluation; 3. Rectal NET with lymph node metastasis or distant metastasis; 4. Received resection of rectal neuroendocrine tumor by other surgical procedures; 5. Multiple rectal neuroendocrine tumors; 6. Vulnerable groups such as pregnant women or patients with mental disorders; 7. Poor compliance, unable to cooperate with treatment.

Design outcomes

Primary

MeasureTime frameDescription
histological complete resectionwithin 14 days after procedurecomplete single-piece (en bloc) resection of the targeted lesion with horizontal and vertical free margins.

Secondary

MeasureTime frameDescription
success rate of operationintraoperativethe proportion of patients whose tumors were successfully resected in each group
en bloc resectionintraoperativecomplete single resection of the targeted lesion, irrespective of whether the basal and lateral tumor margins were infiltrated or undetermined
operation timeintraoperativethe time required to complete the procedure, was taken from the first submucosal injection to the end of complete resection of the targeted area or a failure or complication of the procedure which required discontinuation
complicationswithin 14 days after procedureperforation or hemorrhage during or after operation.
length of staywithin 14 days after procedurecalculated from the day of admission to day of discharge
operation costwithin 14 days after procedurethe cost of UEMR or ESD procedures, except the cost of other endoscopic procedures
hospitalization costwithin 14 days after procedurerepresent the hospital's costs of being hospitalized
histopathologic gradewithin 14 days after procedureNET grade 1, NET grade 2, NET grade 3, and NEC

Countries

China

Contacts

CONTACTZelong Han, MD
hanzelong2025@163.com+86 20-6278-7385
CONTACTBitao Lin, MD
linbitao1996@163.com+86 137-2532-1385

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 13, 2026